Lupin receives tentative FDA approval for Revefenacin Inhalation Solution

Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System

AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension

Akeso reports results from Phase II trial of ligufalimab combination therapy in AML

US FDA approves Datar Cancer Genetics' comprehensive genomic profiling assay for solid tumours

US FDA approves Lupin's Famotidine Injection USP

Kelun-Biotech's SKB118 PD-1 x VEGF bispecific antibody receives Chinese regulatory Investigational New Drug approval

Servier's Emi-Le receives US FDA breakthrough therapy designation for adenoid cystic carcinoma

Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook

Cellular Intelligence and Novo Nordisk enter agreement to advance clinical-stage Parkinson's cell therapy

Transpire Bio's generic high-strength Trelegy Ellipta ANDA accepted for filing by US FDA

Vector Science & Therapeutics secures three-year manufacturing partnership with MPP Group to expand peptide pipeline

Oncopeptides plans EMA filing to broaden Pepaxti indication

GSK partners with SBP Group to accelerate China launch of bepirovirsen

Harbour BioMed's HBM7004 receives US FDA IND clearance for Phase I trial